Latest Breaking News On - Pharmaceutical systems - Page 8 : comparemela.com

BD Announces First Fiscal Quarter Results; Raises Fiscal 2021 Guidance - First fiscal quarter revenues of $5.315 billion grew 25.8% on a reported basis. On a currency-neutral basis, revenues increased 24.3%. - BD s COVID-19 testing sales of $867 million contributed 20.5 percentage points to revenue growth on a reported basis. This includes BD Veritor™ Plus System revenues of $688 million. - First fiscal quarter GAAP diluted earnings per share (EPS) increased 285% year-over-year to $3.35. - Adjusted EPS increased 71.7% year-over-year to $4.55. - BD is updating its fiscal 2021 guidance, including raising its fiscal 2021 adjusted EPS guidance to $12.75-$12.85. News provided by Share this article Share this article FRANKLIN LAKES, N.J., Feb. 4, 2021 /PRNewswire/ BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $5.315 billion for the first fiscal quarter ended December 31, 2020. This represents

United statesUnited kingdomSaudi arabiaTom polenTroy kirkpatrickKristenm stewartChild programAbseq immune discovery panelMedication management solutionsWorld of healthMedication delivery solutionsBd life sciencesExchange commissionCorporate communicationsHuman rights campaignFoundation best places to work